Tag Archives: cas-am
CAS-AM: Week 2, Day 3
CAS-AM: Shaping the Future of Thrombosis Care Exciting day in training the new antithrombotic management experts: Portfolio Discussions with faculty. Following the first training week, participants worked on their CAS-AM portfolios reflecting and providing evidence of the development of antithrombotic … Continue reading
CAS-AM: Week 2, Day 2
CAS-AM: Shaping the Future of Thrombosis Care With a focus on “PE in elderly subject with multiple CV risk factors”, the 2nd day of the second CAS-AM course week started with the post-discussion, followed by a combined lecture on the … Continue reading
CAS-AM: Week 2, Day 1
CAS-AM: Shaping the Future of Thrombosis Care After a long summer in which the participants completed their portfolio, it’s time for the second CAS-AM course week. The first day started with a combined lecture on DOAC pharmokinetics and drug-drug interactions … Continue reading
CAS-AM: Week 1, Day 4
CAS-AM: Shaping the Future of Thrombosis Care Day 4 and last day of the 1st week of the CAS-AM antithrombotic management course. Closing the week with great lectures by experts on antiphospholipid syndrome (Stéphane ZUILY, @Rolf Urbanus), thrombosis and pregnancy … Continue reading
CAS-AM: Week 1, Day 3
CAS-AM: Shaping the Future of Thrombosis Care Update on day 3 of the CAS-AM antithrombotic management course. Realizing that a course is all about good, enthusiastic, and integrating participants, a snapshot into the hard work that they deliver. From pre-discussions in team sessions to small … Continue reading
CAS-AM: Week 1, Day 2
CAS-AM: Shaping the Future of Thrombosis Care During the 2nd training day on antithrombotic management, participants started with a lively post discussion on VTE and cancer, guided with great enthusiasm by Nick van Es and Marcello Di Nisio. The lead-out … Continue reading
CAS-AM: Week 1, Day 1
CAS-AM: Shaping the Future of Thrombosis Care The first day of the CAS-AM course started with an introduction by Hugo Ten cate, followed by the 1st case on antithrombotic management in cancer associated venous thrombosis. Two tutorial groups followed the … Continue reading